Challenges and Opportunities in the Management of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH)

September 23, 2019

This publication reviews the impact of advanced fibrosis due to nonalcoholic steatohepatitis (NASH) as well as current treatment landscape, drugs in development, and future (and unmet) for patients with this progressive disease.

This publication reviews the impact of advanced fibrosis due to nonalcoholic steatohepatitis (NASH) as well as current treatment landscape, drugs in development, and future (and unmet) for patients with this progressive disease.